111In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified …
DL Costantini, C Chan, Z Cai, KA Vallis… - Journal of Nuclear …, 2007 - Soc Nuclear Med
The cytotoxicity and tumor-targeting properties of the anti-HER2/neu monoclonal antibody
trastuzumab modified with peptides (CGYG PKKKRKV GG) harboring the nuclear …
trastuzumab modified with peptides (CGYG PKKKRKV GG) harboring the nuclear …
111) In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu …
DL Costantini, C Chan, Z Cai… - Journal of nuclear …, 2007 - pubmed.ncbi.nlm.nih.gov
The cytotoxicity and tumor-targeting properties of the anti-HER2/neu monoclonal antibody
trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring the nuclear localization …
trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring the nuclear localization …
[PDF][PDF] 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai, KA Vallis, RM Reilly - J Nucl Med, 2007 - scholar.archive.org
MB-231 cells was minimal. 111In-NLS-trastuzumab was 6-fold more effective at killing SK-
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
[PDF][PDF] 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai, KA Vallis, RM Reilly - J Nucl Med, 2007 - Soc Nuclear Med
MB-231 cells was minimal. 111In-NLS-trastuzumab was 6-fold more effective at killing SK-
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
(111) In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu …
DL Costantini, C Chan, Z Cai, KA Vallis… - Journal of Nuclear …, 2007 - europepmc.org
Methods Trastuzumab was derivatized with sulfosuccinimidyl-4-(N-maleimidomethyl)
cyclohexane-1-carboxylate (sulfo-SMCC) for reaction with NLS-peptides and labeled with …
cyclohexane-1-carboxylate (sulfo-SMCC) for reaction with NLS-peptides and labeled with …
[PDF][PDF] 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai, KA Vallis, RM Reilly - J Nucl Med, 2007 - researchgate.net
MB-231 cells was minimal. 111In-NLS-trastuzumab was 6-fold more effective at killing SK-
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
(111) In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu …
D Costantini, C Chan, Z Cai, K Vallis… - Journal of nuclear …, 2007 - ora.ox.ac.uk
UNLABELLED: The cytotoxicity and tumor-targeting properties of the anti-HER2/neu
monoclonal antibody trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring …
monoclonal antibody trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring …
[引用][C] 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai, KA Vallis… - Journal of Nuclear …, 2007 - cir.nii.ac.jp
111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS):
An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer …
An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer …
^ sup 111^ In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai… - The Journal of …, 2007 - search.proquest.com
The cytotoxicity and tumor-targeting properties of the anti-HER2/neu monoclonal antibody
trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring the nuclear localization …
trastuzumab modified with peptides (CGYGPKKKRKVGG) harboring the nuclear localization …
[PDF][PDF] 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2 …
DL Costantini, C Chan, Z Cai, KA Vallis, RM Reilly - J Nucl Med, 2007 - Citeseer
MB-231 cells was minimal. 111In-NLS-trastuzumab was 6-fold more effective at killing SK-
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …
BR-3 cells than unlabeled trastuzumab. Formation of gH2AX foci occurred in a greater …